Tesamorelin Tesamorelin Tesamorelin 10mg (Lyophilized Peptide) For Research Use Only Tesamorelin is a synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH), studied for its potential to stimulate endogenous growth hormone secretion in controlled research environments
Typically, intramuscular injections might be given daily during the first week, followed by weekly shots for one month, and then every month or two months for life
N Engl J Med 366:5463 Qiao R, Qiao H, Zhang Y, Wang Y, Chi C, Tian J, Zhang L, Cao F, Gao M (2017) Molecular imaging of vulnerable atherosclerotic plaques in vivo with osteopontin-specific upconversion nanoprobes

Satiety and Food Intake Reduction Cagrilintide's most clinically significant effect is its potent reduction in food intake and enhancement of satiety through activation of AMY1 receptors in the area postrema [14] : Brainstem Satiety Signaling: Area postrema neurons project to nucleus tractus solitarius (NTS), which integrates peripheral satiety signals and regulates feeding behavior [17] Dose-Dependent Effects: Higher doses of cagrilintide produce greater reductions in ad libitum food intake and increased subjective fullness ratings [9] Sustained Effect: Unlike acute satiety signals, cagrilintide's long half-life provides continuous appetite suppression between weekly doses [2] Synergy with GLP-1 Receptor Agonists The combination of cagrilintide with GLP-1 receptor agonists (particularly semaglutide) produces effects greater than either agent alone
Abdomen Stomach fat is perhaps the most requested treatment area